Answers are grounded in this paper and cite their sources.
Currently pharmaceutical manufacturing enterprises are facing the urgent need for digital and intelligent transformation, but how to efficiently use emerging technologies to promote transformation is still an important issue. Based on dynamic capability theory, this paper explores how generative artificial intelligence generated content (AIGC) empowers intelligent manufacturing transformation of pharmaceutical manufacturing enterprises, and combs through its logical mechanism and development strategy. The study shows that AIGC has a profound impact on intelligent manufacturing in terms of knowledge generation, decision optimisation, process automation, etc., and can significantly improve the innovation ability and market responsiveness of enterprises. The research in this paper helps to deepen pharmaceutical manufacturing enterprises' understanding of AIGC-enabled intelligent manufacturing, provide theoretical guidance for enterprise practice, and provide valuable references for policy makers.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: